

Results-oriented pharmacovigilance professional with over 3.5 years of experience in clinical safety operations encompassing drugs, medical devices, vaccines, in vitro devices (IVDs), and software-based devices (SaMD/SiMD). Specialized in end-to-end management of clinical trials, and proficient in signal detection, post-market surveillance, and regulatory submission (EMA, BfArM, Health Canada, FDA, PMDA). Adept at establishing SOPs, developing operations plans, and training frameworks. Recognized for excellence in audit readiness and stakeholder collaboration.
• Managed the safety operations for an oncology study initiation, contributing to the study protocol, safety management plan, complaint plan, and CRF development, leading to timely FPI.
• Streamlined operational workflows by coordinating cross-functional teams for enhanced efficiency.
• Configured ARGUS database in collaboration with IT teams for advanced drug-device hybrid studies.
• Ensured proper data archival during close-out activities for multiple studies, contributing to clean audit findings during client inspections.
• Trained new team members as a subject matter expert, fostering knowledge retention and capability enhancement.
• Engaged in UAT meetings and client communication calls to facilitate project-related activities on schedule.
• Carried out regulatory reporting submissions across various global authorities, maintaining 100% compliance with the applicable guidelines (ICH-GCP, ISO 14155, MDR, and FDA 21 CFR).
• Executed end-to-end case processing involving TRIAGE report review, source document review, case entry, AE coding (MeDRA, IMDRF), dossier preparation, narrative writing, and adjudication across therapeutic areas.
• Documented production processes and maintained accurate records.
• Participated in safety training and adhered to safety protocols.
• Conducted quality checks on raw materials and final products.